The filing is a routine insider intent-to-sell notice with no material impact. Monitor for any subsequent Form 4 filings to confirm whether the sale was executed.
LH drugs
LH drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 4 $367.79entry
- T+1 · 12d ago −1.22%α +3.19% · $363.30
- T+5 · 6d ago +1.21%α +2.12% · $372.23
- T+8 · todayOpen
- T+20 · in 16d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Megan D. Bailey, a former officer of Labcorp Holdings, filed a Form 144 notice of intent to sell 3,035 shares of common stock, with an estimated aggregate market value of approximately $1.1 million. The shares were acquired through a stock option exercise on the same day. The sale is small relative to the company's $29.3B market cap and appears routine.
Key Facts
- Megan D. Bailey, a former officer, filed Form 144 to sell 3,035 shares of Labcorp common stock.
- Estimated aggregate market value of the proposed sale is $1,096,120.60.
- The shares were acquired via a stock option exercise on November 4, 2026.
- The sale is planned for November 4, 2026 on the NYSE.
- The filing represents an intent to sell; the actual sale may not occur.
Financial Impact
Proposed sale of 3,035 shares valued at approximately $1.1 million, representing about 0.0037% of the company's $29.3B market cap.
Risk Factors
- The sale may not be completed; Form 144 only signals intent.
- No additional context on the insider's remaining holdings or selling pattern is provided.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-007719 |
| Document: 0001959173-26-007719-index.html | 0001959173-26-007719 |
| Document: 0001959173-26-007719.txt | 0001959173-26-007719 |
Track record
29 reports on LH
5 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +17.60% at T+60 after the Apr 30, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $372.32 Now $372.46 +0.04% settles Nov 19
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $372.23 Now $372.46 +0.06% settles Nov 18
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $363.30 to $372.32 Now $372.46 +2.52% ▲ +2.48% −0.81% vs SPY
- Nov 4, 202612d ago 144 Neutral 2/10 Viewing Entry $367.79 to $372.23 Now $372.46 +1.27% ▲ +1.21% +2.12% vs SPY
- Nov 4, 202612d ago 8-K Neutral 2/10 Entry $367.79 to $372.23 Now $372.46 +1.27% ▲ +1.21% +2.12% vs SPY
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $353.92 to $370.88 Now $372.46 +5.24% ▲ +4.79% +5.38% vs SPY
- Oct 30, 202617d ago 144 Neutral 2/10 Entry $361.39 to $366.57 Now $372.46 +3.06% ▲ +1.43% +4.14% vs SPY
- Oct 28, 202619d ago 8-K Bullish 6/10 Entry $360.25 to $367.79 Now $372.46 +3.39% ▲ +2.09% +2.81% vs SPY
- Oct 26, 202621d ago Institutional Cluster Neutral 3/10 Entry $329.90 to $361.39 Now $372.46 +12.90% ▲ +9.55% +10.81% vs SPY
- Oct 21, 202626d ago 8-K Neutral 2/10 Entry $323.75 to $331.17 Now $372.46 +15.05% ▲ +2.29% +2.74% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers